TMCnet News

Global Endocrinology Drugs Market 2016-2020 - Increase in Outsourcing - Key Vendors are AbbVie, Sanofi SA & Novo Nordisk AS - Research and Markets

[May 06, 2016]

Global Endocrinology Drugs Market 2016-2020 - Increase in Outsourcing - Key Vendors are AbbVie, Sanofi SA & Novo Nordisk AS - Research and Markets

Research and Markets has announced the addition of the "Global Endocrinology Drugs Market 2016-2020" report to their offering.

The global endocrinology drugs market is expected to grow at a CAGR of 6.69% during the period 2016-2020.

As vendors are facing the problem of a decline in venture capital investment, they are increasingly following the strategy of outsourcing. Different parts of research such as product characterization testing and toxicology testing are outsourced to third-party research organizations.

Similarly, some vendors outsource the pharmaceutical product manufacturing or the entire manufacturing process to contract manufacturing organizations. This reduces the operational costs, as most companies do not have to maintain expensive R&D laboratories and scientists. Pharmaceutical companies rely on the contract manufacturing organizations based in India, China, Russia, and Eastern Europe to manufacture and process their products.

The prevalence of diabetes is rising because of obesity, unhealthy diet, and lack of physical activity among individuals. The prevalence of hypogonadism also increases in men with diabetes, human immunodeficiency virus (HIV), chronic obstructive pulmonary disease, heart or renal disease, or in individuals who are on opiate or glucocorticoid therapy. Thus, the increase in the prevalence of these diseases will lead to the increase in the intake of medications, propelling the market growth.

Further, the report states that the patent expiry of major approved drugs is expected to impact the market adversely and slow down its growth during the forecast period.

Key vendors: